|
|
||||||||
Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine, University of Montréal, Montréal, Québec, Canada H1T 2M4
1Correspondence: Research Center, Maisonneuve-Rosemont Hospital, 5415 blvd. de lAssomption, Montréal, Québec, Canada H1T 2M4. E-mail: filepj{at}ere.umontreal.ca
Antiflammin-1 and antiflammin-2 are nonapeptides corresponding to the region of highest similarity between glucocorticoid-inducible proteins lipocortin-1 and uteroglobin. We have studied whether antiflammins could affect expression of adhesion molecules on human leukocytes and coronary artery endothelial cells (HCAEC) and binding of neutrophils (PMNs) to HCAEC. Although neither antiflammin-1 nor antiflammin-2 affected expression of adhesion molecules on resting PMNs, monocytes, and lymphocytes in whole blood, they attenuated changes in L-selectin and CD11/CD18 expression evoked by platelet-activating factor or interleukin-8 with IC50 values of 420 µmol/l. The maximum inhibition was similar to those seen with human recombinant lipocortin-1 (100 µg/ml). Unlike dexamethasone (100 nmol/l), the antiflammins had little effect on LPS-stimulated expression of E-selectin and ICAM-1 on HCAEC. Consistently, culture of HCAEC with dexamethasone, but not with antiflammins, decreased PMN binding to endothelial cells. Preincubation of PMNs with antiflammins markedly decreased their adhesion to LPS-activated HCAEC. Inhibition of adhesion was additive with function blocking anti-E-selectin and anti-L-selectin antibodies, but was not additive with anti-CD18 antibody. These results show that antiflammins inhibit PMN adhesion to HCAEC by attenuating activation-induced up-regulation of CD11/CD18 expression on leukocytes, and suggest that antiflammins may represent a novel therapeutic approach in blocking leukocyte trafficking in host defense and inflammation.Zouki, C., Ouellet, S., Filep, J. G. The antiinflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells.
Key Words: lipocortin-1-derived peptides L-selectin integrin neutrophil recruitment inflammation
This article has been cited by other articles:
![]() |
T. S. Gastardelo, A. S. Damazo, J. Dalli, R. J. Flower, M. Perretti, and S. M. Oliani Functional and Ultrastructural Analysis of Annexin A1 and Its Receptor in Extravasating Neutrophils during Acute Inflammation Am. J. Pathol., January 1, 2009; 174(1): 177 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dalli, L. V. Norling, D. Renshaw, D. Cooper, K.-Y. Leung, and M. Perretti Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles Blood, September 15, 2008; 112(6): 2512 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. El Kebir, L. Jozsef, and J. G. Filep Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation J. Leukoc. Biol., September 1, 2008; 84(3): 600 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Yang, S. J. Kim, N. Kim, J. E. Oh, J. G. Lee, N. H. Chung, S. Kim, and Y. S. Kim NKT Cells Inhibit the Development of Experimental Crescentic Glomerulonephritis J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1663 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Mukherjee, Z. Zhang, and B. S. Chilton Uteroglobin: A Steroid-Inducible Immunomodulatory Protein That Founded the Secretoglobin Superfamily Endocr. Rev., December 1, 2007; 28(7): 707 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Damazo, S. Yona, R. J. Flower, M. Perretti, and S. M. Oliani Spatial and Temporal Profiles for Anti-Inflammatory Gene Expression in Leukocytes during a Resolving Model of Peritonitis J. Immunol., April 1, 2006; 176(7): 4410 - 4418. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. G. Hayhoe, A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement Blood, March 1, 2006; 107(5): 2123 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Chatterjee, S. Yona, G. Rosignoli, R. E. Young, S. Nourshargh, R. J. Flower, and M. Perretti Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro J. Leukoc. Biol., September 1, 2005; 78(3): 639 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Damazo, S. Yona, F. D'Acquisto, R. J. Flower, S. M. Oliani, and M. Perretti Critical Protective Role for Annexin 1 Gene Expression in the Endotoxemic Murine Microcirculation Am. J. Pathol., June 1, 2005; 166(6): 1607 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perretti and R. J. Flower Annexin 1 and the biology of the neutrophil J. Leukoc. Biol., July 1, 2004; 76(1): 25 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, J. J. Shim, P.-R. Burgel, I. F. Ueki, T. Dao-Pick, D. C.-W. Tam, and J. A. Nadel IL-13-induced Clara cell secretory protein expression in airway epithelium: role of EGFR signaling pathway Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L67 - L75. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. LA, M. D'AMICO, S. BANDIERA, C. DI FILIPPO, S. M. OLIANI, F. N. E. GAVINS, R. J. FLOWER, and M. PERRETTI Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action FASEB J, October 1, 2001; 15(12): 2247 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Moreno Antiflammin-2 Prevents HL-60 Adhesion to Endothelial Cells and Prostanoid Production Induced by Lipopolysaccharides J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 884 - 889. [Abstract] [Full Text] |
||||
![]() |
S. M. Oliani, M. J. Paul-Clark, H. C. Christian, R. J. Flower, and M. Perretti Neutrophil Interaction with Inflamed Postcapillary Venule Endothelium Alters Annexin 1 Expression Am. J. Pathol., February 1, 2001; 158(2): 603 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Wagner and R. A. Roth Neutrophil Migration Mechanisms, with an Emphasis on the Pulmonary Vasculature Pharmacol. Rev., September 1, 2000; 52(3): 349 - 374. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |